論文

査読有り
2004年12月

Chemokines and autoimmune diseases

Current Medicinal Chemistry: Anti-Inflammatory and Anti-Allergy Agents
  • Tomoya Katakai
  • ,
  • Akira Shimizu

3
4
開始ページ
341
終了ページ
350
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.2174/1568014043355221

Autoimmune diseases are caused by a misdirection of the host immune system against the self. After the triggering of self-reactivity, two successive phases, i.e. the acute/deterioration phase and subsequent chronic phase are observed during the course of manifestation and maintenance of autoimmune symptoms. Not only inflammatory chemokines but also homeostatic chemokines are involved in effector cells' migration and the development of tertiary lymphoid tissue in the target tissue. In the acute/deterioration phase, Th1-associated chemokines and a vicious cycle of type 1 immune responses are crucial for the destruction of the tissue. Subsequently, homeostatic chemokines play important roles in organizing ectopic lymphoid tissue for sustaining autoreactivity in the chronic phase. If they are only correctly directed toward invasive pathogens, immune responses are, essentially, an evolutionally acquired function of the adaptive immune system, which is quite efficient for eradicating non-self. However, if self-components accidentally happen to become the target of the host immune system, a serious situation ensues. For clinical treatment, both inflammatory and homeostatic chemokines would be promising targets in the different phases of autoimmune diseases. © 2004 Bentham Science Publishers Ltd.

リンク情報
DOI
https://doi.org/10.2174/1568014043355221
ID情報
  • DOI : 10.2174/1568014043355221
  • ISSN : 1568-0142
  • SCOPUS ID : 9244244143

エクスポート
BibTeX RIS